# The Enzymatic Activity of Lymphocyte Dihydropyrimidine Dehydrogenase DPD in the Blood as a Predictive and Prognostic Factor in Patients With Digestive Cancer in the First or Second Metastatic Line

> **NCT03205735** · — · UNKNOWN · sponsor: **Centre Antoine Lacassagne** · enrollment: 200 (estimated)

## Conditions studied

- Metastatic or Locally-advanced Digestive Cancer

## Interventions

- **DIAGNOSTIC_TEST:** lymphocyte DPD dosage

## Key facts

- **NCT ID:** NCT03205735
- **Lead sponsor:** Centre Antoine Lacassagne
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** UNKNOWN
- **Start date:** 2017-06-29
- **Primary completion:** 2021-09-29
- **Final completion:** 2021-12-29
- **Target enrollment:** 200 (ESTIMATED)
- **Last updated:** 2021-07-02


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03205735

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03205735, "The Enzymatic Activity of Lymphocyte Dihydropyrimidine Dehydrogenase DPD in the Blood as a Predictive and Prognostic Factor in Patients With Digestive Cancer in the First or Second Metastatic Line". Retrieved via AI Analytics 2026-05-30 from https://api.ai-analytics.org/clinical/NCT03205735. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*